Sei Investments CO Protagonist Therapeutics, Inc Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Sei Investments CO holds 35,078 shares of PTGX stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,078

Previous 41,763 16.01%

Holding current value

$1.43 Million

Previous $1.45 Million 8.91%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$33.72 - $47.33 $225,418 - $316,401	-6,685 Reduced 16.01%	35,078 $1.58 Million
Q2 2024 Aug 13, 2024	BUY	$24.66 - $34.8 $123 - $174	5 Added 0.01%	41,763 $1.45 Million
Q1 2024 May 07, 2024	BUY	$21.79 - $32.15 $98,686 - $145,607	4,529 Added 12.17%	41,758 $1.21 Million
Q4 2023 Feb 14, 2024	SELL	$14.05 - $23.44 $41,967 - $70,015	-2,987 Reduced 7.43%	37,229 $853,000
Q3 2023 Nov 14, 2023	SELL	$16.68 - $23.66 $530,424 - $752,388	-31,800 Reduced 44.16%	40,216 $670,000
Q2 2023 Aug 11, 2023	BUY	$18.02 - $29.36 $655,513 - $1.07 Million	36,377 Added 102.07%	72,016 $1.99 Million
Q1 2023 May 12, 2023	SELL	$10.78 - $25.38 $3,298 - $7,766	-306 Reduced 0.85%	35,639 $819,000
Q4 2022 Feb 10, 2023	SELL	$7.36 - $11.17 $4,541 - $6,891	-617 Reduced 1.69%	35,945 $392,000
Q3 2022 Nov 14, 2022	SELL	$7.86 - $11.71 $663,721 - $988,827	-84,443 Reduced 69.78%	36,562 $308,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $25.52 $68,573 - $247,875	-9,713 Reduced 7.43%	121,005 $957,000
Q1 2022 May 13, 2022	SELL	$23.34 - $36.08 $37,227 - $57,547	-1,595 Reduced 1.21%	130,718 $3.1 Million
Q4 2021 Feb 14, 2022	BUY	$17.63 - $37.1 $1.52 Million - $3.2 Million	86,138 Added 186.55%	132,313 $4.53 Million
Q3 2021 Nov 12, 2021	SELL	$12.95 - $49.69 $781,649 - $3 Million	-60,359 Reduced 56.66%	46,175 $818,000
Q2 2021 Aug 06, 2021	BUY	$25.57 - $44.88 $502,552 - $882,071	19,654 Added 22.62%	106,534 $4.78 Million
Q1 2021 May 12, 2021	BUY	$19.02 - $31.15 $1.65 Million - $2.71 Million	86,880 New	86,880 $2.25 Million

Others Institutions Holding PTGX

# of Institutions

247

Shares Held

56.4M

Call Options Held

76.3K

Put Options Held

114K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Protagonist Therapeutics, Inc Transaction History